Mizuho Maintains Neutral on Amgen, Raises Price Target to $235
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Salim Syed has maintained a Neutral rating on Amgen (NASDAQ:AMGN) and increased the price target from $223 to $235.

May 09, 2024 | 11:48 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mizuho analyst Salim Syed maintains a Neutral rating on Amgen and raises the price target from $223 to $235.
The adjustment in price target by Mizuho reflects a positive outlook on Amgen's valuation, albeit maintaining a Neutral stance suggests that the analyst sees limited upside potential or existing risks that could cap significant stock price appreciation in the short term. The increase in price target could lead to a mild positive sentiment among investors, but the neutral rating tempers expectations for a strong bullish movement.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100